Averin Capital Acquisition Corp. filed its quarterly report on Form 10-Q for the period ended September 30, 2026 with the U.S. Securities and Exchange Commission, covering the company's financial condition and operations as a Cayman Islands exempted blank-check company.
Key Highlights
- Share count: As of November 13, 2026, the company had 28,586,008 Class A Ordinary Shares and 7,096,502 Class B Ordinary Shares issued and outstanding, each with a par value of $0.0001 per share.
- IPO closing date: The company completed its Initial Public Offering on February 20, 2026, establishing a 24-month Combination Period running to February 20, 2028.
- Over-Allotment exercise: The underwriters partially exercised their over-allotment option, purchasing 3,386,008 Option Units out of a maximum 3,750,000 available.
- Deferred underwriting fee: A deferred aggregate fee of $15,612,304 is payable to the underwriters only upon completion of an initial Business Combination.
- Trust Account access: The company may withdraw up to $500,000 per year from Trust Account interest for working capital, plus additional amounts to cover tax obligations, according to the filing.
- Exchange listings: Class A Ordinary Shares trade on NASDAQ:ACAA; warrants trade as NASDAQ:ACAAW; units trade as NASDAQ:ACAAU.
Averin Capital's SPAC Structure and Combination Timeline
According to the filing, Averin Capital Acquisition Corp. is organized as a Cayman Islands exempted company and is classified as a shell company under Rule 12b-2 of the Exchange Act. The company is also designated as a non-accelerated filer, a smaller reporting company, and an emerging growth company. Its principal offices are located at 240 W 40th Street, Office 205, New York, New York 10018.
The filing discloses that the company's IPO Registration Statement was initially filed on January 30, 2026, and declared effective on February 18, 2026. The company entered into an Administrative Services Agreement with its Sponsor on February 18, 2026, the same date it executed a Letter Agreement with its Sponsor and its directors and officers. Continental Stock Transfer & Trust Company serves as trustee of the Trust Account and warrant agent for the company's warrants, as described in the filing.
The filing states that the company's Combination Period extends to February 20, 2028, or May 20, 2028 if a definitive agreement for an initial Business Combination is in place by February 20, 2028. The filing also references the "Nasdaq 36-Month Requirement," described as the rule requiring a SPAC to complete one or more Business Combinations within 36 months following the effectiveness of its initial public offering registration statement. Deutsche Bank Securities Inc. is identified as the representative of the underwriters, and the IPO Promissory Note is described as an unsecured note in a principal amount of up to $300,000, issued to the Sponsor on October 21, 2025.
What Was Disclosed
Averin Capital Acquisition Corp. filed its Form 10-Q for the quarterly period ended September 30, 2026, disclosing share counts, trust account terms, underwriting arrangements, and the timeline for completing an initial Business Combination. The filing confirms the company remains a shell company with three classes of securities listed on Nasdaq. The deferred underwriting fee of $15,612,304 is contingent on completing a Business Combination, and working capital withdrawals from the Trust Account are subject to defined annual limits.




Please wait processing your request...